Crunch week looms for Sanofi, Roche and GSK at U.S. drugs agency

LONDON (Reuters) - Three of Europe's top drugmakers face critical verdicts from U.S. regulators next week, with Sanofi and Roche likely to win approvals for two new products, while GlaxoSmithKline braces for a potential generic rival.